Skip to content

Katherine Everly, DO

NPI 1073209375ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Kansas City, KS

Internal Medicine, Endocrinology, Diabetes & Metabolism (DO) in Kansas City, Kansas, licensed in KS and IA, with an NPI issued in April 2023. Part D covered 33 prescriptions written in 2024, 88% of them generic. Amgen Inc. was the largest of 3 companies reporting payments in 2025, $96.34 in all, mostly food and beverage.

Overview

NPI1073209375
StatusActive
Entity typeIndividual
CredentialDO
Sole proprietorNo
NPI issuedApr 11, 2023
Last updated in NPPESMay 10, 2026
Certified by providerMay 10, 2026

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Internal Medicine (IA)

Part D prescriptions in 2024

Prescriptions (claims)33 · 33 30-day fills
Patients21
Total drug cost$1,856
Generic share88% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$96.34 · 3 payments from 3 companies
  • 2024$63.39 · 3 payments from 3 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$96.34 · 3 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other endocrinologists in Kansas City

All 22 endocrinologists in Kansas City · All endocrinologists in Kansas